An in-depth look to SYNCORE BIOTECHNOL operating, investing, and financing activities

4192 free cash flow for Q3 24 is -12.64 M TWD. For 2023, 4192 free cash flow was -82.39 M TWD and operating cash flow was -81.98 M TWD.